Skip to main content

Want a detailed portfolio tracker?

Sigilon Therapeutics (SGTX) Return on Equity (ROE) (2020 - 2023)

Sigilon Therapeutics (SGTX) Return on Equity (ROE) from Dec 31, 2020 to Jun 30, 2023. The TTM Sigilon Therapeutics (SGTX) Return on Equity (ROE) is -27.35%. You can export chart.

Annual ROE

Quarterly ROE

Annual Return on Equity (ROE) change of Sigilon Therapeutics (SGTX)

YearReturn on Equity (ROE)Change
2022-111.29%
+11.08%
2021-100.19%
+168.16%
2020-37.36%
N/A